Osteosarcoma of the jaws (OSJ) is a relatively rare disease, accounting for between 2% and 10% of all cases of osteosarcoma. It is morphologically and radiologically identical to the trunk and extremity variant, but distinct in several crucial aspects. The lesion is characterized by sarcomatous cells which produce a variable amount of osteoid bone. It arises centrally within the bone and can be subdivided into osteoblastic, chondroblastic and fibroblastic subtype, depending on the predominant cell type. Radiographically, these tumors display a spectrum of bone changes from well-demarcated borders to lytic bone destruction with indefinite margins and variable cortical bone erosion or, in some cases, images of sclerotic bone. Therapeutic options for OSJ include surgery, chemotherapy and radiotherapy, which are employed according to age of the patient, histological classification and localization of the tumor. Today, there is no general consensus in the treatment guidelines for the OSJ though surgery represents the key to the treatment. The main prognostic factor deeply influencing the patient's prognosis remains the complete tumor resection with negative surgical margins. The aim of the present review is to describe state of the art regarding diagnostic and surgical treatment aspects of the primary osteosarcoma of the jaws.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/1573405616666200806173948 | DOI Listing |
Cureus
November 2024
Histopathology, Jordanian Royal Medical Services, Amman, JOR.
Osteosarcoma (OS) is a rare form of malignant bone tumor affecting jaws. The diagnosis of jaws osteosarcoma (JO) presents a unique challenge due to its rarity and the diversity of histological presentations it can exhibit. Fibroblastic osteosarcoma (FO), a subtype of OS, is characterized by the presence of fibroblastic cells and osteoid-producing cells within the tumor matrix.
View Article and Find Full Text PDFCureus
November 2024
Surgery, National and Kapodistrian University of Athens, School of Medicine, Athens, GRC.
One of the most important figures of the Hellenic surgery of the 19 century, professor of the Othonian University of Athens, Theodoros Aretaios (1829-1893), portrays in his personal archives a series of surgical operations in the field of maxillofacial surgery. During his career, he operated the following surgical diseases, these are adenosarcomas or inosarcomas of the parotid region, osteofibroma of the sinus antrum, osteosarcomas of the upper and lower jaw, and lycostoma (cleft palate). He was able to perform radical enucleations of the tumorous masses.
View Article and Find Full Text PDFCureus
November 2024
Department of Pediatric Dentistry, Medical University "Prof. Dr. Paraskev Stoyanov", Varna, BGR.
Cementoblastoma is a benign odontogenic mesenchymal tumor characterized by cementum production. Cementoblastoma is considered a relatively rare neoplasm with a predilection to the posterior region of the mandible. The main clinical differential diagnoses include hypercementosis, cemento-osseous dysplasia, condensing osteitis, idiopathic osteosclerosis, osteoblastoma, odontoma, and osteosarcoma.
View Article and Find Full Text PDFTissue Cell
December 2024
Animal Health Research Institute, Dokki, Giza PO 12618, Egypt; Ministry of Environment, Water and Agriculture, Fish Welfare Branch, El-Jubail Province, Saudi Arabia.
During routine veterinary inspection of fish from fishing boats, fish auction yards, and fish landing stations, as well as the large fish market for detection of fish diseases, abnormalities and/or overgrowth in body surfaces and evaluation of hygienic conditions and fish quality at El-Jubail Province, Saudi Arabia., external neoplastic overgrowths were observed in two fish species, giant sea catfish (Arius thalassinus) and Delagoa threadfin bream (Nemipterus bipunctatu). In both fishes, the neoplasms appeared as bony masses, and it was hard in its consistency.
View Article and Find Full Text PDFHead Neck Pathol
November 2024
Department of Pathology, Cleveland Clinic, Cleveland, OH, USA.
Jaw osteosarcoma (JOS) is a rare, distinct variant that differ from long bone osteosarcoma (LBOS) in several aspects. JOS typically appears about twenty years later than LBOS, displays a lower propensity for metastasis to other organs, and exhibits better survival rates. The dissimilarities in clinical and biological behavior between JOS and LBOS are likely due, at least in part, to variations in their respective microenvironments.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!